USE OF MENADIONE TO INCREASE SALIN STRESS TOLERANCE IN PLANTS USE OF MENADIONE TO INCREASE SALIN STRESS TOLERANCE IN PLANTS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOUND INTENDED FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF PENTACYCLIC TRITERPENE IN A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MULTIPLE SCLEROSIS USE OF PENTACYCLIC TRITERPENE IN A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MULTIPLE SCLEROSIS
USE OF PHOTOSENSITIVE AGENT CAPABLE OF PRODUCING REACTIVE OXYGEN SPECIES IN THE PRODUCTION OF A DRUG FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS IN VITRO USE AND PHARMACEUTICAL COMPOSITION USE OF PHOTOSENSITIVE AGENT CAPABLE OF PRODUCING REACTIVE OXYGEN SPECIES IN THE PRODUCTION OF A DRUG FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS IN VITRO USE AND PHARMACEUTICAL COMPOSITION
USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION